Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases

Keyphrases

• Endothelial Cells 100%
• Peripheral Arterial Disease 100%
• Nitric Oxide Donors 100%
• Nitric Oxide 50%
• Angiogenesis 50%
• Nitric Oxide Release 25%
• Antioxidant 25%
• Oxidative Stress 25%
• Reactive Oxygen Species 25%
• Hydrogen Peroxide 25%
• Nanoparticles 25%
• Factor Level 25%
• Poly(lactic-co-glycolic acid) Nanoparticles 25%
• Vascular Endothelial Growth Factor 25%
• Nitric Oxide Bioavailability 25%
• Superoxide 25%
• Matrigel 25%
• Induced Oxidative Stress 25%
• Platelets 25%
• Tube Formation Assay 25%
• Tube Formation 25%
• Hybrid Molecules 25%
• Copolymer 25%
• Therapeutic Angiogenesis 25%
• Peripheral Ischemia 25%
• Peroxynitrite Anion 25%
• 5-Amino-1 25%
• Alternative Therapy 25%
• Leukocyte Chemotaxis 25%
• Sustained Release 25%
• Ischemic Events 25%
• Aqueous Stability 25%
• Oxadiazole 25%
• Piperidone 25%
• Smooth muscle Cells 25%
• Stress Conditions 25%
• Therapeutic Levels 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Nitric Oxide 100%
• Peripheral Occlusive Artery Disease 100%
• Nitric Oxide Donor 100%
• Nanoparticle 50%
• Reactive Oxygen Metabolite 25%
• Polyglactin 25%
• Vasculotropin 25%
• Bioavailability 25%
• Hydrogen Peroxide 25%
• Antioxidant 25%
• Superoxide 25%
• Matrigel 25%
• Copolymer 25%
• Sustained Release 25%
• Peripheral Ischemia 25%
• Peroxynitrite 25%